Norman Sharpless | |
---|---|
15th Director of the National Cancer Institute | |
In office October 17, 2017 – April 30, 2022 | |
President | Donald Trump Joe Biden |
Preceded by | Harold E. Varmus Douglas R. Lowy (acting) |
Succeeded by | Monica Bertagnolli |
Acting Commissioner of Food and Drugs | |
In office April 5, 2019 – November 1, 2019 | |
President | Donald Trump |
Secretary | Alex Azar |
Preceded by | Scott Gottlieb |
Succeeded by | Brett Giroir (acting) |
Personal details | |
Born | Greensboro, North Carolina | September 20, 1966
Nationality | American |
Alma mater | |
Known for | p16LUC model |
Scientific career | |
Fields | Molecular genetics |
Institutions | |
Norman Edward "Ned" Sharpless (born September 20, 1966) is the previous Director of the National Cancer Institute (NCI). Before that, Sharpless was Professor of Medicine and Genetics Chair, Director of University of North Carolina UNC Lineberger Comprehensive Cancer Center, Molecular Therapeutics, Wellcome Distinguished Professorship in Cancer Research.[1]
Sharpless was named to head the NCI on June 10, 2017,[2] and took office on October 17, 2017. Sharpless also served as Acting Commissioner of the Food and Drugs from April 5, 2019[3][4] until November 1, 2019, after which he returned to the NCI.[5] He stepped down from the post at the end of April 2022.[6][7]